196 related articles for article (PubMed ID: 32869954)
1. Pediatric and young adult renal cell carcinoma.
Ray S; Jones R; Pritchard-Jones K; Dzhuma K; van den Heuvel-Eibrink M; Tytgat G; van der Beek J; Oades G; Murphy D
Pediatr Blood Cancer; 2020 Nov; 67(11):e28675. PubMed ID: 32869954
[TBL] [Abstract][Full Text] [Related]
2. Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.
Geller JI; Dome JS
Cancer; 2004 Oct; 101(7):1575-83. PubMed ID: 15378495
[TBL] [Abstract][Full Text] [Related]
3. Renal cell carcinoma in children and adolescents.
Spreafico F; Collini P; Terenziani M; Marchianò A; Piva L
Expert Rev Anticancer Ther; 2010 Dec; 10(12):1967-78. PubMed ID: 21110762
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of renal cell carcinoma in children in Germany, 1980-2005: more frequently localized tumors and underlying disorders compared with adult counterparts.
Selle B; Furtwängler R; Graf N; Kaatsch P; Bruder E; Leuschner I
Cancer; 2006 Dec; 107(12):2906-14. PubMed ID: 17109448
[TBL] [Abstract][Full Text] [Related]
5. Factors related to lymph node sampling at the time of surgery in children, adolescents, and young adults with unilateral non-metastatic renal cell carcinoma.
Saltzman AF; Stokes W; Walker J; Cost NG
J Pediatr Urol; 2019 May; 15(3):259.e1-259.e7. PubMed ID: 30819622
[TBL] [Abstract][Full Text] [Related]
6. Treatment of advanced pediatric renal cell carcinoma.
Ambalavanan M; Geller JI
Pediatr Blood Cancer; 2019 Aug; 66(8):e27766. PubMed ID: 31012542
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant Therapy for Localized High-Risk Renal Cell Carcinoma.
Wood E; Donin N; Shuch B
Urol Clin North Am; 2020 Aug; 47(3):345-358. PubMed ID: 32600536
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant Therapy Options in Renal Cell Carcinoma: Where Do We Stand?
Martinez Chanza N; Tripathi A; Harshman LC
Curr Treat Options Oncol; 2019 May; 20(5):44. PubMed ID: 31054006
[TBL] [Abstract][Full Text] [Related]
9. Pediatric renal cell carcinoma.
Craig KM; Poppas DP; Akhavan A
Curr Opin Urol; 2019 Sep; 29(5):500-504. PubMed ID: 31261184
[TBL] [Abstract][Full Text] [Related]
10. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract][Full Text] [Related]
11. Metastatic renal cell carcinoma without evidence of a renal primary.
Costantino C; Thomas GV; Ryan C; Coakley FV; Troxell ML
Int Urol Nephrol; 2016 Jan; 48(1):73-7. PubMed ID: 26527083
[TBL] [Abstract][Full Text] [Related]
12. Renal cell carcinoma.
Whang YE; Godley PA
Curr Opin Oncol; 2003 May; 15(3):213-6. PubMed ID: 12778014
[TBL] [Abstract][Full Text] [Related]
13. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
14. Distinguishing pediatric and adolescent renal cell carcinoma from other renal malignancies.
Syed JS; Nguyen KA; Wu CQ; Cost NG; Siddiqui MM; Hittelman AB; Shuch B
Pediatr Blood Cancer; 2017 May; 64(5):. PubMed ID: 27805307
[TBL] [Abstract][Full Text] [Related]
15. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and treatment of renal cell carcinoma in children: a report from the Polish pediatric rare tumor study group.
Stachowicz-Stencel T; Bien E; Balcerska A; Godzinski J; Synakiewicz A; Perek-Polnik M; Kurylak A; Pietras W; Kuzmicz M; Mizia-Malarz A; Rybczynska A; Nurzynska-Flak J
Klin Padiatr; 2011 May; 223(3):138-41. PubMed ID: 21509711
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive Analysis of Survival Outcomes in Non-Clear Cell Renal Cell Carcinoma Patients Treated in Clinical Trials.
de Velasco G; McKay RR; Lin X; Moreira RB; Simantov R; Choueiri TK
Clin Genitourin Cancer; 2017 Dec; 15(6):652-660.e1. PubMed ID: 28410911
[TBL] [Abstract][Full Text] [Related]
18. Pediatric and adolescent renal cell carcinoma.
Young EE; Brown CT; Merguerian PA; Akhavan A
Urol Oncol; 2016 Jan; 34(1):42-9. PubMed ID: 26299882
[TBL] [Abstract][Full Text] [Related]
19. Cytoreductive radiofrequency ablation in patients with metastatic renal cell carcinoma (RCC) with small primary tumours treated with sunitinib or interferon-α.
Tsimafeyeu I; Zart JS; Chung B
BJU Int; 2013 Jul; 112(1):32-8. PubMed ID: 23746142
[TBL] [Abstract][Full Text] [Related]
20. Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with renal cell carcinoma.
García Del Muro X; Gallardo E; García Carbonero I; Laínez N; José Méndez M; Maroto P; Ochoa de Olza M; Puente J; Reynes G; Rubio J; Santander C; Suárez C; Vázquez Estévez S; Castellano D
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1095-107. PubMed ID: 24531612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
